| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): scale presentation and clinimetric testing results CG Goetz, BC Tilley, SR Shaftman, GT Stebbins, S Fahn, ... Movement disorders: official journal of the Movement Disorder Society 23 (15 …, 2008 | 3288 | 2008 |
| Clinical diagnostic criteria for dementia associated with Parkinson's disease M Emre, D Aarsland, R Brown, DJ Burn, C Duyckaerts, Y Mizuno, GA Broe, ... Movement disorders: official journal of the Movement Disorder Society 22 (12 …, 2007 | 2327 | 2007 |
| MDS clinical diagnostic criteria for Parkinson's disease RB Postuma, D Berg, M Stern, W Poewe, CW Olanow, W Oertel, J Obeso, ... Movement disorders 30 (12), 1591-1601, 2015 | 2090 | 2015 |
| Levodopa and the progression of Parkinson's disease Parkinson Study Group New England Journal of Medicine 351 (24), 2498-2508, 2004 | 1812 | 2004 |
| A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease CW Olanow, CG Goetz, JH Kordower, AJ Stoessl, V Sossi, MF Brin, ... Annals of neurology 54 (3), 403-414, 2003 | 1625 | 2003 |
| Etiology and pathogenesis of Parkinson's disease CW Olanow, WG Tatton Annual review of neuroscience 22 (1), 123-144, 1999 | 1600 | 1999 |
| Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease JH Kordower, Y Chu, RA Hauser, TB Freeman, CW Olanow Nature medicine 14 (5), 504-506, 2008 | 1452 | 2008 |
| Variable expression of Parkinson's disease: A base‐line analysis of the DAT ATOP cohort J Jankovic, M McDermott, J Carter, S Gauthier, C Goetz, L Golbe, S Huber, ... Neurology 40 (10), 1529-1529, 1990 | 1198 | 1990 |
| Oxidative stress and the pathogenesis of Parkinson's disease P Jenner, CW Olanow Neurology 47 (6 Suppl 3), 161S-170S, 1996 | 1164 | 1996 |
| Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease JH Kordower, TB Freeman, BJ Snow, FJG Vingerhoets, EJ Mufson, ... New England Journal of Medicine 332 (17), 1118-1124, 1995 | 988 | 1995 |
| Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): process, format, and clinimetric testing plan CG Goetz, S Fahn, P Martinez‐Martin, W Poewe, C Sampaio, GT Stebbins, ... Movement disorders 22 (1), 41-47, 2007 | 974 | 2007 |
| An algorithm (decision tree) for the management of Parkinson’s disease (2001):: Treatment Guidelines CW Olanow, RL Watts, WC Koller Neurology 56 (suppl 5), S1-S88, 2001 | 955 | 2001 |
| A radical hypothesis for neurodegeneration CW Olanow Trends in neurosciences 16 (11), 439-444, 1993 | 948 | 1993 |
| The scientific and clinical basis for the treatment of Parkinson disease (2009) CW Olanow, MB Stern, K Sethi Neurology 72 (21 Supplement 4), S1-S136, 2009 | 944 | 2009 |
| International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study KR Chaudhuri, P Martinez‐Martin, AHV Schapira, F Stocchi, K Sethi, ... Movement disorders: official journal of the Movement Disorder Society 21 (7 …, 2006 | 911 | 2006 |
| Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force B Dubois, D Burn, C Goetz, D Aarsland, RG Brown, GA Broe, D Dickson, ... Movement disorders 22 (16), 2314-2324, 2007 | 899 | 2007 |
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease CW Olanow, O Rascol, R Hauser, PD Feigin, J Jankovic, A Lang, ... New England Journal of Medicine 361 (13), 1268-1278, 2009 | 883 | 2009 |
| Pathophysiology of the basal ganglia in Parkinson's disease JA Obeso, MC Rodriguez-Oroz, M Rodriguez, JL Lanciego, J Artieda, ... Trends in neurosciences 23, S8-S19, 2000 | 880 | 2000 |
| Understanding cell death in Parkinson's disease P Jenner, CW Olanow Annals of neurology 44 (S1 1), S72-S84, 1998 | 820 | 1998 |
| Evidence of neuronal oxidative damage in Alzheimer's disease. PF Good, P Werner, A Hsu, CW Olanow, DP Perl The American journal of pathology 149 (1), 21, 1996 | 768 | 1996 |
Olivier RASCOLUT3 Professor, CHU Purpan, Tonic (INSERM-UT3), CIC 1436 (INSERM-CHU-UT3), TMBI (Univ. Toulouse)Verified email at univ-tlse3.fr
